scholarly journals In Pursuit: A Mother’s Account of Her Son’s Rare Disease Diagnosis Journey

2021 ◽  
Vol 8 (4) ◽  
pp. 360-362
Author(s):  
Anne M Jones
2019 ◽  
Vol 206 ◽  
pp. 1-4
Author(s):  
Nima Niknejad ◽  
Hamed Jafar-Nejad

Author(s):  
Vanessa L. Merker ◽  
Scott R. Plotkin ◽  
Martin P. Charns ◽  
Mark Meterko ◽  
Justin T. Jordan ◽  
...  

2020 ◽  
Vol 8 ◽  
Author(s):  
Carla S. D'Angelo ◽  
Azure Hermes ◽  
Christopher R. McMaster ◽  
Elissa Prichep ◽  
Étienne Richer ◽  
...  

Advances in omics and specifically genomic technologies are increasingly transforming rare disease diagnosis. However, the benefits of these advances are disproportionately experienced within and between populations, with Indigenous populations frequently experiencing diagnostic and therapeutic inequities. The International Rare Disease Research Consortium (IRDiRC) multi-stakeholder partnership has been advancing toward the vision of all people living with a rare disease receiving an accurate diagnosis, care, and available therapy within 1 year of coming to medical attention. In order to further progress toward this vision, IRDiRC has created a taskforce to explore the access barriers to diagnosis of rare genetic diseases faced by Indigenous peoples, with a view of developing recommendations to overcome them. Herein, we provide an overview of the state of play of current barriers and considerations identified by the taskforce, to further stimulate awareness of these issues and the passage toward solutions. We focus on analyzing barriers to accessing genetic services, participating in genomic research, and other aspects such as concerns about data sharing, the handling of biospecimens, and the importance of capacity building.


2020 ◽  
Vol 11 ◽  
Author(s):  
Zhichao Liu ◽  
Ruth Roberts ◽  
Tieliu Shi ◽  
Mike Mikailov ◽  
Weida Tong

2018 ◽  
Author(s):  
Feichen Shen ◽  
Sijia Liu ◽  
Yanshan Wang ◽  
Andrew Wen ◽  
Liwei Wang ◽  
...  

BACKGROUND In the United States, rare diseases are defined as those affecting fewer than 200,000 patients at any given time. Patients with rare diseases are frequently either misdiagnosed or left undiagnosed, possibly due in part to a lack of knowledge or experience with the rare disease on the part of care providers. With an exponentially growing volume of electronically accessible medical data, a large volume of information on thousands of rare diseases and their potentially associated diagnostic information is buried in electronic medical records (EMRs) and medical literature. OBJECTIVE We hypothesize that patients’ phenotypic information available within these heterogeneous resources (e.g., electronic medical records and biomedical literature) can be leveraged to accelerate disease diagnosis. In this study, we aimed to leverage information contained in heterogeneous datasets to assist rare disease diagnosis. METHODS In a previous study, we proposed utilizing a collaborative filtering recommendation system enriched with natural language processing and semantic techniques to assist rare disease diagnosis based on phenotypic characterizations derived solely from EMR data. In this study, in order to further investigate the performance of collaborative filtering on heterogeneous datasets, we studied EMR data generated at Mayo Clinic as well as published article abstracts retrieved from the Semantic MEDLINE Database. Specifically, in this study, we applied Tanimoto coefficient similarity, overlap coefficient similarity, Fager & McGowan coefficient similarity, and log likelihood ratio similarity with K nearest neighbor and threshold based patient neighbor algorithms on various combinations of datasets. RESULTS We evaluated different approaches to this problem using characterizations derived from various combinations of EMR data and literature, as well as with solely EMR data. We extracted 12.8 million EMRs from the Mayo Clinic unstructured patient cohort generated between 2010 through 2015 and retrieved all article abstracts from the semi-structured Semantic MEDLINE Database that were published through the end of 2016. We applied a collaborative filtering model and compared the performance generated by different metrics. Log likelihood ratio similarity combined with K nearest neighbor on heterogeneous datasets showed the optimal performance in patient recommendation with PRAUC 0.475 (string match), 0.511 (SNOMED match), and 0.752 (GARD match). Log likelihood ratio similarity also performed the best with mean average precision 0.465 (string match), 0.5 (SNOMED match), and 0.749 (GARD match). Performance of rare disease prediction was also demonstrated by using the optimal algorithm. Macro-average F-measure for string, SNOMED-CT, and GARD match were 0.32, 0.42, and 0.63, respectively. CONCLUSIONS This study demonstrated potential utilization of heterogeneous datasets in a collaborative filtering model to support rare disease diagnosis. In addition to phenotypic-based analysis, in the future, we plan to resolve the heterogeneity issue and reduce miscommunication between EMR and literature by mining genotypic information to establish a comprehensive disease-phenotype-gene network for rare disease diagnosis.


Sign in / Sign up

Export Citation Format

Share Document